Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Xu-Bao Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5108122373. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
30
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 2 papers · 2025: none · 2026: 1 paper

Papers 8

  1. Time to reclassify? The prognostic value of radiologic splenic vessel involvement in resectable pancreatic ductal adenocarcinoma of the body and tail: a system… Co-author DOI 10.1097/js9.0000000000003927↗
  2. Clusterin is upregulated by erastin, a ferroptosis inducer and exerts cytoprotective effects in pancreatic adenocarcinoma cells. Co-author DOI 10.1097/cad.0000000000001561↗
  3. Overcome the challenge for intratumoral injection of STING agonist for pancreatic cancer by systemic administration. Co-author DOI 10.1186/s13045-024-01576-z↗
  4. Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis. Last author DOI 10.4251/wjgo.v14.i10.1903↗
  5. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study. Last author DOI 10.1097/md.0000000000019327↗
  6. Recurrence and survival after surgery for pancreatic cancer with or without acute pancreatitis. Co-author DOI 10.3748/wjg.v25.i39.6006↗
  7. Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN. Co-author DOI 10.1016/j.yexcr.2017.10.033↗
  8. MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy. Last author DOI 10.18632/oncotarget.22494↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunlu Tan · 6 shared papers, 2017–2026 · strength 1.08
  2. Qingquan Tan · 2 shared papers, 2024–2026 · strength 0.59
  3. Xing Wang · 2 shared papers, 2024–2026 · strength 0.59
  4. Yonghua Chen · 3 shared papers, 2019–2022 · strength 0.43
  5. Ziying Yao · 1 shared paper, 2026 · strength 0.33
  6. Zhenjiang Zheng · 2 shared papers, 2020–2022 · strength 0.32
  7. Yichen Li · 1 shared paper, 2024 · strength 0.26
  8. Yonghua Chen · 1 shared paper, 2024 · strength 0.26
  9. Haoqi Zhang · 1 shared paper, 2022 · strength 0.19
  10. Jing Li · 1 shared paper, 2022 · strength 0.19
  11. Mengni He · 1 shared paper, 2024 · strength 0.16
  12. Noelle R. Jurcak · 1 shared paper, 2024 · strength 0.16
  13. Brian T. Herbst · 1 shared paper, 2024 · strength 0.16
  14. Nan Niu · 1 shared paper, 2024 · strength 0.16
  15. Junke Wang · 1 shared paper, 2024 · strength 0.16
  16. Keyu Li · 1 shared paper, 2024 · strength 0.16
  17. Noah S Rozich · 1 shared paper, 2024 · strength 0.16
  18. Chunhui Yuan · 1 shared paper, 2024 · strength 0.16
  19. Lei Zheng · 1 shared paper, 2024 · strength 0.16
  20. Arsen Osipov · 1 shared paper, 2024 · strength 0.16
  21. Alex B. Blair · 1 shared paper, 2024 · strength 0.16
  22. Ailin Wei · 2 shared papers, 2017 · strength 0.13
  23. Weiming Hu · 2 shared papers, 2017 · strength 0.13
  24. Junjie Xiong · 2 shared papers, 2017 · strength 0.13
  25. Dan Wang · 2 shared papers, 2017 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.